202005.31
0

Ecosystem Weekly | 31st May ’20

IndoStar Capital Finance raises $162 Mn from Brookfield With this investment, Brookfield will become a co-promoter with 24.6% stake, along with IndoStar Capital Mauritius having 45.2% holding at present Read More Serum Institute parent sells Czech unit to Novavax for $167 mn Cyrus Poonawalla Group, the parent of vaccine developer Serum Institute of India has sold a…

202005.25
0

Ecosystem Weekly | 24th May ’20

Reliance’s Jio Platforms raises $1.5B from private equity giant KKR The investment follows significant fund infusions in Jio Platforms from Facebook ($5.7 Bn), Silver Lake Partners ($747 Mn), Vista Equity Partners ($1.5 Bn), and General Atlantic ($870 Mn) Read More Abu Dhabi’s ADQ announces new $300m VC fund to invest in Indian startups ADQ has…

202005.17
0

Ecosystem Weekly | 17th May ’20

Carlyle to take over SeQuent Scientific in its biggest India control deal PE firm Carlyle has agreed to acquire up to 74% of animal healthcare company SeQuent Scientific Ltd for $210 Mn in what would be its biggest control-oriented deal in India Read More Sequoia India bets more on Indonesian coffee chain Kopi Kenangan Sequoia…

202005.10
0

Ecosystem Weekly | 10th May ’20

GSK sells $3.35 Bn stakes in Hindustan Unilever GlaxoSmithKline sold its stake in Unilever’s Indian business for $3.35 Bn, which Refinitiv says is the largest block trade ever to have been carried out in India. Read More Reliance gets third investor for Jio, sells $1.5 bn stake to Vista Equity US-based Vista Equity Partners will…

202005.03
0

6 Sins in Marketing

Potential mistakes by brands during and post the pandemic Aravind Thippanaik As countries and companies limp back to normalcy, consumer companies will go into overdrive to gain back lost ground. Instinctively, brands will try to latch on to the “flavors of the season” – Health (Immunity), Safety (Protection/Hygiene), Hope (Better tomorrow). Brands may stretch across…

202005.03
0

Ecosystem Weekly | 3rd May ’20

M&A-minded Piramal near $500M deal to sell pharma stake to KKR India’s Piramal Enterprises may sell a 20% minority stake in the pharma unit—a slice valued at $500 million—to private equity giant KKR & Co. Read More Paytm in funding talks with Microsoft to build war chest The proposed fundraise, which may amount to around…